⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20160786 | 0.64 | — | — | |
| SCHEMBL4365635 | 0.58 | MEN1 (0.33) | — | |
| SCHEMBL3679428 | 0.58 | — | — | |
| SCHEMBL378762 | 0.55 | — | — | |
| SCHEMBL16178868 | 0.52 | — | — | |
| SCHEMBL651428 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL1332061 | 0.47 | — | — | |
| SCHEMBL9314153 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL30620980 | 0.47 | MEN1 (0.75) | — | |
| SCHEMBL8378095 | 0.47 | MEN1 (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110719916-B | Anti-TRKB antibodies | 勃林格殷格翰国际有限公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024099816-A1 | METHOD, LIPOSOME COLLECTION, AND KIT FOR DETERMINING COMPLEMENT ACTIVITY | UNIVERSITÄT REGENSBURG (DE) | 2024-05-16 | — | — | WO | disclosed |
| US-20240101689-A1 | ANTI-TRKB ANTIBODIES | BOEHRINGER INGELHEIM INT (DE) | 2024-03-28 | — | — | US | disclosed |
| US-11866501-B2 | Anti-TrkB antibodies | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-01-09 | — | — | US | disclosed |
| US-11059879-B2 | Chimeric antigen receptor molecules and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-07-13 | — | — | US | disclosed |
| US-20200399378-A1 | ANTI-TRKB ANTIBODIES | BOEHRINGER INGELHEIM INT (DE) | 2020-12-24 | — | — | US | disclosed |
| US-10793634-B2 | Anti-TrkB antibodies | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2020-10-06 | — | — | US | disclosed |
| EP-3635004-A1 | ANTI-TRKB ANTIBODIES | Boehringer Ingelheim International GmbH (DE) | 2020-04-15 | — | — | EP | disclosed |
| US-10610504-B2 | Alpha-cell re-generation combined with conversion to beta cells | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-04-07 | — | — | US | disclosed |
| EP-3368075-B1 | CHIMERIC ANTIGEN RECEPTOR MOLECULES AND USES THEREOF | UNIV TEXAS (US) | 2020-01-29 | — | — | EP | disclosed |
| US-20030165875-A1 | Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof | BIOXELL S.P.A. (IT) | 2003-09-04 | — | — | US | disclosed |
| EP-0638119-B1 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | YEDA RES & DEV (IL) | 2003-06-11 | — | — | EP | disclosed |
| US-20020137697-A1 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | CABARET BIOTECH LTD. (IL) | 2002-09-26 | — | — | US | disclosed |
| WO-2001092291-A2 | ANTIBODY AND T-CELL RECEPTOR LIBRARIES | GALIM - GALIL IMMUNOLOGY LTD. (IL) | 2001-12-06 | — | — | WO | disclosed |
| EP-0969867-A2 | USE OF ANTI-IL-12 ANTIBODIES IN TRANSPLANTATION REJECTION | Strom, Terry (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999022766-A2 | USE OF ANTI-IL-12 ANTIBODIES IN TRANSPLANTATION REJECTION | STROM TERRY (US) | 1999-05-14 | — | — | WO | disclosed |
| EP-0638119-A4 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH. | YEDA RES & DEV (IL) | 1997-06-18 | — | — | EP | disclosed |
| WO-1997015669-A1 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-05-01 | — | — | WO | disclosed |
| EP-0638119-A1 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1995-02-15 | — | — | EP | disclosed |
| WO-1993019163-A1 | CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH | YEDA RESEARCH AND DEVELOPMENT CO, LTD. (IL) | 1993-09-30 | — | — | WO | disclosed |